LYFT vs TERN · P/E 108, rev $5.79B vs $6.12B cap
LYFT Inc (LYFT) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
LYFT currently screens at market cap $6.79B and trailing P/E 107.7. TERN currently screens at market cap $6.12B.
Not investment advice. Open the LYFT and TERN stock pages for the full models.
Not investment advice.